Insider · CIK 0001313403

Colangelo Dominick

Reports to the SEC for 3 companies · NEW HAVEN, CT

sec.gov

Transactions

Companies

Filings

CIK

0001313403

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-06-03	TRVITrevi Therapeutics, Inc. · Nonstatutory Stock Option (right to buy)A Award	Director	AAward	+35K sh	—	—	35,000
2026-02-24	VCELVericel CorpM Exercise/Conversion	Director, President and CEO	MExercise/Conversion	+18.3K sh	—	—	303,020
2026-02-24	VCELVericel CorpM Exercise/Conversion	Director, President and CEO	MExercise/Conversion	+18.3K sh	—	—	321,270
2026-02-24	VCELVericel CorpF Tax Payment	Director, President and CEO	FTax Payment	−8,824 sh	$38.09	−$336K	312,446
2026-02-24	VCELVericel Corp · Restricted Stock UnitM Exercise/Conversion	Director, President and CEO	MExercise/Conversion	+18.3K sh	—	—	54,750
2026-02-24	VCELVericel Corp · Restricted Stock UnitM Exercise/Conversion	Director, President and CEO	MExercise/Conversion	+18.3K sh	—	—	36,500
2026-02-19	VCELVericel Corp · Restricted Stock UnitA Award	Director, President and CEO	AAward	+73K sh	—	—	73,000
2026-02-19	VCELVericel Corp · Stock Option (Right to Buy)A Award	Director, President and CEO	AAward	+183K sh	—	—	182,500
2026-02-18	VCELVericel CorpF Tax Payment	Director, President and CEO	FTax Payment	−5,657 sh	$37.41	−$212K	284,770
2026-02-18	VCELVericel Corp · Restricted Stock UnitM Exercise/Conversion	Director, President and CEO	MExercise/Conversion	+11.7K sh	—	—	0
2026-02-18	VCELVericel Corp · Restricted Stock UnitM Exercise/Conversion	Director, President and CEO	MExercise/Conversion	+18.3K sh	—	—	18,250
2026-02-18	VCELVericel CorpM Exercise/Conversion	Director, President and CEO	MExercise/Conversion	+11.7K sh	—	—	290,427
2026-02-18	VCELVericel CorpM Exercise/Conversion	Director, President and CEO	MExercise/Conversion	+18.3K sh	—	—	278,727
2025-06-30	VCELVericel CorpA Award	Director, President and CEO	AAward	+123 sh	$36.17	+$4,448.91	260,477
2025-06-11	TRVITrevi Therapeutics, Inc. · Nonstatutory Stock Option (right to buy)A Award	Director	AAward	+45K sh	—	—	45,000
2025-05-15	VCELVericel CorpM Exercise/Conversion	Director, President and CEO	MExercise/Conversion	+14.1K sh	$2.65	+$37.3K	274,417
2025-05-15	VCELVericel CorpS Sale	Director, President and CEO	SSale	−14.1K sh	$41.53	−$584K	260,354
2025-05-15	VCELVericel Corp · Stock Option (Right to Buy)M Exercise/Conversion	Director, President and CEO	MExercise/Conversion	+14.1K sh	—	—	0
2025-05-14	VCELVericel Corp · Stock Option (Right to Buy)M Exercise/Conversion	Director, President and CEO	MExercise/Conversion	+14.1K sh	—	—	14,063
2025-05-14	VCELVericel CorpS Sale	Director, President and CEO	SSale	−14.1K sh	$42.25	−$594K	260,354
2025-05-14	VCELVericel CorpM Exercise/Conversion	Director, President and CEO	MExercise/Conversion	+14.1K sh	$2.65	+$37.3K	274,416
2025-04-10	VCELVericel Corp · Stock Option (Right to Buy)M Exercise/Conversion	Director, President and CEO	MExercise/Conversion	+24.9K sh	—	—	0
2025-04-10	VCELVericel CorpS Sale	Director, President and CEO	SSale	−24.9K sh	$41.89	−$1.04M	260,354
2025-04-10	VCELVericel CorpM Exercise/Conversion	Director, President and CEO	MExercise/Conversion	+24.9K sh	$2.75	+$68.3K	285,204
2025-04-09	VCELVericel CorpS Sale	Director, President and CEO	SSale	−24.9K sh	$41.11	−$1.02M	260,354
2025-04-09	VCELVericel Corp · Stock Option (Right to Buy)M Exercise/Conversion	Director, President and CEO	MExercise/Conversion	+24.9K sh	—	—	24,850
2025-04-09	VCELVericel CorpM Exercise/Conversion	Director, President and CEO	MExercise/Conversion	+24.9K sh	$2.75	+$68.3K	285,204
2025-03-13	VCELVericel CorpM Exercise/Conversion	Director, President and CEO	MExercise/Conversion	+26.6K sh	$1.95	+$51.9K	286,589
2025-03-13	VCELVericel CorpS Sale	Director, President and CEO	SSale	−26.6K sh	$45.78	−$1.22M	259,997
2025-03-13	VCELVericel Corp · Stock Option (Right to Buy)M Exercise/Conversion	Director, President and CEO	MExercise/Conversion	+26.6K sh	—	—	0
2025-03-12	VCELVericel CorpM Exercise/Conversion	Director, President and CEO	MExercise/Conversion	+26.6K sh	$1.95	+$51.9K	286,588
2025-03-12	VCELVericel Corp · Stock Option (Right to Buy)M Exercise/Conversion	Director, President and CEO	MExercise/Conversion	+26.6K sh	—	—	26,592
2025-03-12	VCELVericel CorpS Sale	Director, President and CEO	SSale	−26.6K sh	$46.31	−$1.23M	259,997
2025-02-24	VCELVericel CorpF Tax Payment	Director, President and CEO	FTax Payment	−8,459 sh	$52.33	−$443K	259,997
2025-02-24	VCELVericel Corp · Restricted Stock UnitM Exercise/Conversion	Director, President and CEO	MExercise/Conversion	+18.3K sh	—	—	54,750
2025-02-24	VCELVericel CorpM Exercise/Conversion	Director, President and CEO	MExercise/Conversion	+18.3K sh	—	—	268,456
2025-02-20	VCELVericel Corp · Stock Option (Right to Buy)A Award	Director, President and CEO	AAward	+183K sh	—	—	182,500
2025-02-20	VCELVericel Corp · Restricted Stock UnitA Award	Director, President and CEO	AAward	+73K sh	—	—	73,000
2025-02-19	VCELVericel CorpF Tax Payment	Director, President and CEO	FTax Payment	−4,196 sh	$57.78	−$242K	250,206
2025-02-19	VCELVericel CorpM Exercise/Conversion	Director, President and CEO	MExercise/Conversion	+8,938 sh	—	—	254,402
2025-02-19	VCELVericel Corp · Restricted Stock UnitM Exercise/Conversion	Director, President and CEO	MExercise/Conversion	+8,938 sh	—	—	0
2025-02-18	VCELVericel Corp · Restricted Stock UnitM Exercise/Conversion	Director, President and CEO	MExercise/Conversion	+18.3K sh	—	—	36,500
2025-02-18	VCELVericel CorpM Exercise/Conversion	Director, President and CEO	MExercise/Conversion	+11.7K sh	—	—	250,887
2025-02-18	VCELVericel Corp · Restricted Stock UnitM Exercise/Conversion	Director, President and CEO	MExercise/Conversion	+11.7K sh	—	—	11,700
2025-02-18	VCELVericel CorpF Tax Payment	Director, President and CEO	FTax Payment	−5,423 sh	$57.28	−$311K	245,464
2025-02-18	VCELVericel CorpM Exercise/Conversion	Director, President and CEO	MExercise/Conversion	+18.3K sh	—	—	239,187
2024-11-14	VCELVericel CorpS Sale	Director, President and CEO	SSale	−17.5K sh	$53.93	−$944K	220,937
2024-11-14	VCELVericel Corp · Stock Option (Right to Buy)M Exercise/Conversion	Director, President and CEO	MExercise/Conversion	+17.5K sh	—	—	0
2024-11-14	VCELVericel CorpM Exercise/Conversion	Director, President and CEO	MExercise/Conversion	+17.5K sh	$3.02	+$52.9K	238,437
2024-11-13	VCELVericel Corp · Stock Option (Right to Buy)M Exercise/Conversion	Director, President and CEO	MExercise/Conversion	+17.5K sh	—	—	17,500

Recent filings

Accepted (ET)
Jun 44
Colangelo Dominick0001193125-26-257370
SEC(opens sec.gov)
Feb 264
Colangelo Dominick0001140361-26-006974
SEC(opens sec.gov)
Feb 204
Colangelo Dominick0001140361-26-006314
SEC(opens sec.gov)
Feb 135
Colangelo Dominick0001140361-26-005418
SEC(opens sec.gov)
Jun 134
Colangelo Dominick0000950170-25-086112
SEC(opens sec.gov)
May 164
Colangelo Dominick0001140361-25-019474
SEC(opens sec.gov)

Companies

Address

C/O TREVI THERAPEUTICS, INC. 195 CHURCH STREET, 16TH FLOOR

NEW HAVEN, CT, 06510